MiƱoza, Mary Joy .
HRN: 19-76-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2024
CEFUROXIME 500MG (TAB)
09/04/2024
09/10/2024
PO
500mg
BID
Nsvd; WBC 21
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes